Año: 2021
Journal Impact Factor (JIF): 7.9890
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PSYCHIATRY | SCIE | 24/155 | Q1 | T1 | D2 |
Año: 2021
Journal Citation Indicator (JCI): 1,580
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| PSYCHIATRY | 25/258 | Q1 | T1 | D1 | 90,50 |
Año:
2021
CiteScore:
8,500
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Psychiatry and Mental Health | 45/529 | Q1 | T1 | D1 |
| Biological Psychiatry | 9/43 | Q1 | T1 | D3 |
| Cellular and Molecular Neuroscience | 19/88 | Q1 | T1 | D3 |
SJR año:
2021
Factor de Impacto:
2,076
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Psychiatry and Mental Health | 27/590 | Q1 | T1 | D1 |
| Biological Psychiatry | 5/49 | Q1 | T1 | D2 |
| Cellular and Molecular Neuroscience | 12/95 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| - | PI13/02434; PI16/01861; PI17/01474; PI19/01301 |
| AbbVie | - |
| Agencia IDEA (Consejeria de Innovacion, Junta de Andalucia) | - |
| AGES contract | N01-AG-12100 |
| Alzheimer's Association | NIRG-11-200110; BAND-14-338165; AARG-16-441560; BFG-15-362540; ADGC-10-196728 |
| Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) | U01 AG024904 |
| Alzheimer's Drug Discovery Foundation | - |
| Alzheimer's Research UK | 503176 |
| Araclon Biotech | - |
| Araclon Biotech S.A. | - |
| BioClinica, Inc. | - |
| Biogen | - |
| Biomedical Research Foundation | - |
| Bristol-Myers Squibb Company | - |
| Canadian Institute of Health Research | - |
| CereSpir, Inc. | - |
| CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) | - |
| Cogstate | - |
| Consejeria de Salud de la Junta de Andalucia | PI-0001/2017 |
| Corporacion Tecnologica de Andalucia | - |
| CurePSP Foundation | - |
| Diabetes Research Laboratory | - |
| DOD ADNI (Department of Defense) | W81XWH12-2-0012 |
| EFPIA companies | - |
| Eisai Inc. | - |
| Elan Pharmaceuticals, Inc. | - |
| Eli Lilly and Company | - |
| Erasmus Medical Center | - |
| Erasmus University | - |
| EuroImmun | - |
| European Union under the Sixth Framework program priority FP6-2004LIFESCIHEALTH-5 | - |
| European Union/EFPIA Innovative Medicines Initiative Joint Undertaking ADAPTED project | 115975 |
| European Union/EFPIA Innovative Medicines Initiative Joint Undertaking MOPEAD project | 115985 |
| F. Hoffmann-La Roche Ltd and its Genentech, Inc. | - |
| Fondo Europeo de Desarrollo Regional (FEDER-"Una manera de Hacer Europa") | - |
| French National Foundation on Alzheimer's Disease and Related Disorders | - |
| Fujirebio | - |
| Fundacio ACE | - |
| Fundacion Alzheimur (Murcia) | - |
| Fundacion bancaria "La Caixa" | - |
| GE Healthcare | - |
| German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) | 01GI0102; 01GI0711; 01GI0420 |
| Grifols SA | - |
| Icelandic Heart Association | - |
| Illinois Department of Public Health | - |
| Inserm | - |
| Institut Pasteur de Lille | - |
| ISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion | - |
| ISCIII (Ministry of Health, Spain) | - |
| IXICO Ltd. | - |
| Janssen Alzheimer Immunotherapy Research & Development, LLC. | - |
| Johnson & Johnson Pharmaceutical Research & Development LLC. | - |
| Kronos Life Sciences Laboratories | - |
| LABEX (laboratory of excellence program investment for the future) DISTALZ grant | - |
| Laboratorios Echevarne | - |
| Lille University Hospital | - |
| Lumosity | - |
| Lundbeck | - |
| Mayo Foundation | - |
| Medical Research Council | 503480 |
| Merck Co., Inc. | - |
| Meso Scale Diagnostics, LLC. | - |
| Ministerio de Educacion y Ciencia (Gobierno de Espana) | - |
| National Alzheimer's Coordinating Center | U01 AG016976 |
| National Institute of Biomedical Imaging and Bioengineering | - |
| National Institute on Aging | - |
| National Institute on Aging (Arizona Alzheimer's Disease Center) | P30 AG19610; RO1 AG023193 |
| National Institute on Aging (Intramural Research Program) | - |
| National Institute on Aging (Mayo Clinic Alzheimer's Disease Center) | P50 AG16574 |
| National Institutes of Health | R01AG044546; P01AG003991; RF1AG053303; R01AG058501; U01AG058922; RF1AG058501; R01AG057777 |
| NeuroRx Research | - |
| Neurotrack Technologies | - |
| NHLBI | R01 HL105756 |
| NIA | P50 AG016574; R01 AG032990; U01 AG046139; R01 AG018023; U01 AG006576; U01 AG006786; R01 AG025711; R01 AG017216; R01 AG003949; P30AG10161; R01AG15819; R01AG17917; R01AG30146; R01AG36836; U01AG32984; U01AG46152; AG081220 |
| NIA Division of Neuroscience | U01-AG032984 |
| NIH | P50 AG05681; P01 AG03991; P01 AG026276 |
| NIH/NIA | U01 AG016976; R01 AG033193; U01 AG032984; U24 AG021886 |
| NINDS | R01 NS080820 |
| Novartis Pharmaceuticals Corporation | - |
| Pfizer Inc. | - |
| Piramal AG | - |
| Piramal Imaging | - |
| Servier | - |
| SMEs as part of InnoMed (Innovative Medicines in Europe) | - |
| state of Arizona | - |
| Takeda Pharmaceutical Company | - |
| Transition Therapeutics | - |
| Translational Genomics Research Institute | - |
| Universite de Lille 2 | - |
| Wellcome Trust | 082604/2/07/Z |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Moreno-Grau, Sonia | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 2 | Fernández, María Victoria | Washington University School of Medicine in St. Louis (United States) |
| 3 | de Rojas, Itziar | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 4 | García-González, Pablo | Universitat Internacional de Catalunya (Spain) |
| 5 | Hernández, Isabel | Universitat Internacional de Catalunya (Spain) |
| 6 | Farias, Fabiana | Washington University School of Medicine in St. Louis (United States) |
| 7 | Budde, John P. | Washington University School of Medicine in St. Louis (United States) |
| 8 | Quintela, Inés | Universidad de Santiago de Compostela (Spain) |
| 9 | Madrid, Laura | Centro Andaluz de Estudios Bioinformáticos (CAEBi) (Spain) |
| 10 | González-Pérez, Antonio | Centro Andaluz de Estudios Bioinformáticos (CAEBi) (Spain) |
| 11 | Montrreal, Laura | Universitat Internacional de Catalunya (Spain) |
| 12 | Alarcón-Martín, Emilio | Universitat Internacional de Catalunya (Spain) |
| 13 | Alegret, Montserrat | Universitat Internacional de Catalunya (Spain) |
| 14 | Maroñas, Olalla | Universidad de Santiago de Compostela; Washington University School of Medicine in St. Louis (United States) |
| 15 | Pineda, Juan Antonio | Hospital Universitario de Valme (Spain) |
| 16 | Macías, Juan | Hospital Universitario de Valme (Spain) |
| 17 | Marquié, Marta | Sin datos () |
| 18 | Valero, Sergi | Sin datos () |
| 19 | Benaque, Alba | Sin datos () |
| 20 | Clarimón, Jordi | Sin datos () |
| 21 | Bullido, María Jesús | Sin datos () |
| 22 | García-Ribas, Guillermo | Sin datos () |
| 23 | Pástor, Pau | Sin datos () |
| 24 | Sánchez-Juan, Pascual | Sin datos () |
| 25 | Álvarez, Victoria | Sin datos () |
| 26 | Piñol-Ripoll, Gerard | Sin datos () |
| 27 | García-Alberca, José María | Sin datos () |
| 28 | Royo, José Luis | Sin datos () |
| 29 | Franco-Macías, Emilio | Sin datos () |
| 30 | Mir, Pablo | Sin datos () |
| 31 | Calero, Miguel | Sin datos () |
| 32 | Medina, Miguel | Sin datos () |
| 33 | Rábano, Alberto | Sin datos () |
| 34 | Ávila, Jesús | Sin datos () |
| 35 | Antúnez, Carmen | Sin datos () |
| 36 | Real, Luis Miguel | Sin datos () |
| 37 | Orellana, Adelina | Sin datos () |
| 38 | Carracedo, Ángel | Sin datos () |
| 39 | Sáez, María Eugenia | Sin datos () |
| 40 | Tárraga, Lluís | Sin datos () |
| 41 | Boada, Mercè | Sin datos () |
| 42 | Cruchaga, Carlos | Sin datos () |
| 43 | Sin datos () | |
| # | Autoría grupal | Afiliación |
| 1 | GR@CE study group | Sin datos () |
| 1 | DEGESCO consortium, | Sin datos () |
| 2 | Alzheimer's disease neuroimaging initiative | Sin datos () |
| 3 | Labrador Espinosa, M. A. (DEGESCO consortium) | Sin datos () |
| 4 | Periñán, María Teresa (DEGESCO consortium) | Sin datos () |
